Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA

New research labs and process development services to enable next generation therapeutics

25-Nov-2024 - Sartorius Stedim Biotech opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed to foster collaboration, co-development and learning on site with customers and other external innovation partners, applying Sartorius' latest ...

Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland

Reducing the cost and risks of scaling-up biologic medicine production

20-Jun-2024 - TheCelonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland. This laboratory expansion will help pharmaceutical companies develop and optimize ...

Lonza to Establish Strategic Biomanufacturing Base in China

13-Dec-2018 - Lonza announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN). As the facility is part of a larger biomanufacturing initiative between GE Healthcare and Guangzhou Development District (GDD), the agreement will be finalized ...

Abzena invests in expansion of biotherapeutics and makes executive appointment

07-Nov-2018 - Dr. Jonathan Goldman, CEO, announced that Abzena has augmented existing 500 L scale biologics equipment with $20M of investment into two new manufacturing suites at 500 L and 2000 L scale in a new GMP facility in San Diego, which will be equipped with Sartorius single use bioreactors. Abzena’s ...

Merck and Samsung BioLogics to Extend Strategic Alliance

02-Nov-2017 - Merck announced the signing of a Memorandum of Understanding (MoU) with Samsung BioLogics for a strategic alliance on biopharmaceutical manufacturing and biologics process development. The alliance would accelerate process development and clinical material production at small biotech start-ups ...

BRAIN and PS Biotech announce cooperation

15-Jun-2016 - B.R.A.I.N. Biotechnology Research and Information Network AG and the startup PS Biotech from Aachen cooperate in the field of the optimization of biotechnological production processes. Within the context of the strategic alliance NatLifE 2020 which started into the second funding period and is ...

Novasep opens new 2,000 m2 expanded Shanghai facilities to meet increasing East Asia demand

New site increases Novasep’s process development and engineering capabilities to supply turnkey purification processes in East Asia

28-Mar-2012 - Novasep announced the opening of a new 2,000 m2 facility in Shanghai Pudong district, China. The site will boost Novasep's process development and engineering capabilities to cater for ever-increasing Chinese and East Asian demand. These facilities will also add to Novasep’s existing 12 global ...

BioSystem Development and BAC BV collaborate to bring purification ligands to high throughput biotherapeutic process development

08-Nov-2010 - BioSystem Development and BAC BV announced a collaboration to bring state-of-the-art high affinity ligands to the AssayMAP high-throughput micro-chromatography platform. This collaboration marks an essential objective toward growing a family of high-throughput tools for micro-scale purification ...

Enzymicals AG Acquires Proprietary Rights on Pig Liver Esterases (PLE) from Evonik AG

15-Oct-2010 - The Enzymicals AG gained proprietary rights for the well-known recombinant pig liver esterases (PLE) from Evonik AG in Hanau. The intellectual property (IP) covers a range of PLE isoenzymes for hydrolysis of several compounds such as esters of secondary and tertiary alcohols, lactones and ...

Almac continues biocatalysis business growth with a further $4m R&D investment

11-Oct-2010 - The need for green, economic, robust and scaleable processes for the synthesis of chiral APIs and intermediates prompted Almacto build and fully integrate a biocatalysis group into its service portfolio. Last year Almac launched carbonyl reductase, transaminase, hydrolase, nitrilase, and nitrile ...